Pages that link to "Q36440077"
Jump to navigation
Jump to search
The following pages link to Shared monocyte subset phenotypes in HIV-1 infection and in uninfected subjects with acute coronary syndrome (Q36440077):
Displaying 50 items.
- Interferon-alpha, immune activation and immune dysfunction in treated HIV infection (Q26861003) (← links)
- Monocytes as regulators of inflammation and HIV-related comorbidities during cART (Q27006827) (← links)
- Markers of coagulation and inflammation often remain elevated in ART-treated HIV-infected patients (Q27024262) (← links)
- The role of statins in the setting of HIV infection (Q27027724) (← links)
- Immunologic predictors of coronary artery calcium progression in a contemporary HIV cohort (Q30593046) (← links)
- Dynamics of immune reconstitution and activation markers in HIV+ treatment-naïve patients treated with raltegravir, tenofovir disoproxil fumarate and emtricitabine (Q31146636) (← links)
- Coagulation and morbidity in treated HIV infection (Q33614424) (← links)
- Initiation of antiretroviral therapy at high CD4 cell counts: does it reduce the risk of cardiovascular disease? (Q33649200) (← links)
- Soluble CD14 is independently associated with coronary calcification and extent of subclinical vascular disease in treated HIV infection (Q33899641) (← links)
- Residual immune dysregulation syndrome in treated HIV infection (Q34020121) (← links)
- Protease inhibitor monotherapy is associated with a higher level of monocyte activation, bacterial translocation and inflammation (Q34288534) (← links)
- Sex Differences in monocytes and TLR4 associated immune responses; implications for systemic lupus erythematosus (SLE) (Q34323715) (← links)
- Chronic HIV disease and activation of the coagulation system (Q34342368) (← links)
- Immune activation and HIV persistence: implications for curative approaches to HIV infection (Q34351320) (← links)
- Monocyte-activation phenotypes are associated with biomarkers of inflammation and coagulation in chronic HIV infection (Q34396067) (← links)
- Sevelamer does not decrease lipopolysaccharide or soluble CD14 levels but decreases soluble tissue factor, low-density lipoprotein (LDL) cholesterol, and oxidized LDL cholesterol levels in individuals with untreated HIV infection (Q34430215) (← links)
- HIV vasculopathy: role of mononuclear cell-associated Krüppel-like factors 2 and 4. (Q34494208) (← links)
- Elevated soluble CD163 plasma levels are associated with disease severity in patients with hemorrhagic fever with renal syndrome (Q34505966) (← links)
- Sex differences in monocyte activation in systemic lupus erythematosus (SLE). (Q34653871) (← links)
- Rosuvastatin preserves renal function and lowers cystatin C in HIV-infected subjects on antiretroviral therapy: the SATURN-HIV trial (Q34736818) (← links)
- Elevated plasma soluble CD14 and skewed CD16+ monocyte distribution persist despite normalisation of soluble CD163 and CXCL10 by effective HIV therapy: a changing paradigm for routine HIV laboratory monitoring? (Q34784783) (← links)
- IL-1Β enriched monocytes mount massive IL-6 responses to common inflammatory triggers among chronically HIV-1 infected adults on stable anti-retroviral therapy at risk for cardiovascular disease (Q35005668) (← links)
- Effect of Nadir CD4+ T cell count on clinical measures of periodontal disease in HIV+ adults before and during immune reconstitution on HAART. (Q35023018) (← links)
- The CD14 C-260T single nucleotide polymorphism (SNP) modulates monocyte/macrophage activation in treated HIV-infected individuals (Q35030351) (← links)
- Characterization of lipid composition and high-density lipoprotein function in HIV-infected individuals on stable antiretroviral regimens (Q35036648) (← links)
- Cardiovascular disease risk in an aging HIV population: not just a question of biology. (Q35064091) (← links)
- Rosuvastatin reduces vascular inflammation and T-cell and monocyte activation in HIV-infected subjects on antiretroviral therapy (Q35102167) (← links)
- Monocytes expand with immune dysregulation and is associated with insulin resistance in older individuals with chronic HIV. (Q35108968) (← links)
- Brief report: Endothelial colony-forming cells and inflammatory monocytes in HIV. (Q35171099) (← links)
- Acute Spontaneous Coronary Artery Thrombosis as Initial Presentation of HIV Infection in a Young Man. (Q35187972) (← links)
- Plasma levels of cytokines and chemokines and the risk of mortality in HIV-infected individuals: a case-control analysis nested in a large clinical trial (Q35629714) (← links)
- Oxidized LDL Levels Are Increased in HIV Infection and May Drive Monocyte Activation. (Q35655728) (← links)
- Altered Monocyte Phenotype in HIV-1 Infection Tends to Normalize with Integrase-Inhibitor-Based Antiretroviral Therapy (Q35796695) (← links)
- Higher levels of circulating monocyte-platelet aggregates are correlated with viremia and increased sCD163 levels in HIV-1 infection (Q35833625) (← links)
- Highly Active Antiretroviral Therapy (HAART)-Related Hypertriglyceridemia Is Associated With Failure of Recovery of CD14lowCD16+ Monocyte Subsets in AIDS Patients (Q35857927) (← links)
- Anaemia is associated with monocyte activation in HIV-infected adults on antiretroviral therapy (Q35935289) (← links)
- Differential Reduction in Monocyte Activation and Vascular Inflammation With Integrase Inhibitor-Based Initial Antiretroviral Therapy Among HIV-Infected Individuals (Q35965242) (← links)
- Changes in Inflammation and Immune Activation With Atazanavir-, Raltegravir-, Darunavir-Based Initial Antiviral Therapy: ACTG 5260s (Q35974422) (← links)
- Elevation of Non-Classical (CD14+/lowCD16++) Monocytes Is Associated with Increased Albuminuria and Urine TGF-β1 in HIV-Infected Individuals on Stable Antiretroviral Therapy. (Q35994939) (← links)
- Plasma CXCL10, sCD163 and sCD14 Levels Have Distinct Associations with Antiretroviral Treatment and Cardiovascular Disease Risk Factors (Q36063953) (← links)
- Traditional and HIV-specific risk factors for cardiovascular morbidity and mortality among HIV-infected adults in Brazil: a retrospective cohort study (Q36098224) (← links)
- Effects of atorvastatin on biomarkers of immune activation, inflammation, and lipids in virologically suppressed, human immunodeficiency virus-1-infected individuals with low-density lipoprotein cholesterol <130 mg/dL (AIDS Clinical Trials Group Stu (Q36341298) (← links)
- Chronic Psoriatic Skin Inflammation Leads to Increased Monocyte Adhesion and Aggregation (Q36390768) (← links)
- Immune activation and cardiovascular disease in chronic HIV infection (Q36556082) (← links)
- The Association of Human Cytomegalovirus with Biomarkers of Inflammation and Immune Activation in HIV-1-Infected Women (Q36601953) (← links)
- Vitamin D, D-dimer, Interferon γ, and sCD14 Levels are Independently Associated with Immune Reconstitution Inflammatory Syndrome: A Prospective, International Study (Q36645092) (← links)
- Markers of inflammation and CD8 T-cell activation, but not monocyte activation, are associated with subclinical carotid artery disease in HIV-infected individuals. (Q36807389) (← links)
- Innate immune reconstitution with suppression of HIV-1. (Q36865871) (← links)
- Circulating levels of tissue factor microparticle procoagulant activity are reduced with antiretroviral therapy and are associated with persistent inflammation and coagulation activation among HIV-positive patients (Q36930484) (← links)
- Inflammation, immune activation, and cardiovascular disease in HIV. (Q36957752) (← links)